TY - JOUR T1 - A secure and rapid query-software for COVID-19 test results that can easily be integrated into the clinical workflow to avoid communication overload JF - medRxiv DO - 10.1101/2020.04.07.20056887 SP - 2020.04.07.20056887 AU - Gunnar Völkel AU - Axel Fürstberger AU - Julian D. Schwab AU - Silke D. Kühlwein AU - Thomas Gscheidmeier AU - Johann M. Kraus AU - Alexander Groß AU - Florian Kohlmayer AU - Peter Kuhn AU - Klaus A. Kuhn AU - Oliver Kohlbacher AU - Thomas Seufferlein AU - Hans A. Kestler Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/11/2020.04.07.20056887.abstract N2 - Overcoming the COVID-19 crisis requires new ideas and strategies. Rapid testing of a large number of subjects is essential to monitor, and delay, the spread of SARS-CoV-2 to mitigate the consequences of the pandemic. People not knowing that they are infected may not stay in quarantine and, thus, are a risk for infecting others. Unfortunately, the massive number of COVID-19 tests performed is challenging for both laboratories and the units that take the throat swab and have to communicate test results. Here, we present a secure tracking system (CTest) to report COVID-19 test results online as soon as they become available. The system can be integrated into the clinical workflow with very modest effort and avoids excessive load to telephone hotlines. With this open-source and browser-based online tracking system, we aim to minimize the time required to inform the tested person but also the test units, e.g. hospitals or the public healthcare system. Instead of personal calls, CTest updates the status of the test automatically when the test results are available. Test reports are published on a secured web-page enabling regular status checks also by patients not using smartphones with dedicated mobile apps which has some importance as smartphone usage diminishes with age.The source code, as well as further information to integrate CTest into the IT environment of other clinics or test-centres, are freely available from https://github.com/sysbio-bioinf/CTest under the Eclipse Public License v2.0 (EPL2).Competing Interest StatementThe authors have declared no competing interest.Funding StatementKAK, HAK and OK acknowledge, funding from the Germany Federal Ministry of Education and Research (BMBF) as part of the DIFUTURE project (Medical Informatics Initiative, grant numbers 01ZZ1804I and 01ZZ1804D). OK and HAK acknowledge funding from the Ministry of Science and Art Baden-Württemberg (Zentrum für Innovative Versorgung, ZIV). OK and TS acknowledge funding from the Ministry of Social Affairs of the state of Baden-Württemberg (Zentren für Personalisierte Medizin, ZPM), HAK also acknowledges funding from the German Science Foundation (DFG, grant number 217328187).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesA software is freely available from https://github.com/sysbio-bioinf/CTest under the Eclipse Public License v2.0 (EPL2). https://github.com/sysbio-bioinf/CTest ER -